HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths

Med J Aust. 2015 May 18;202(9):479. doi: 10.5694/mja15.00165.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Australia / epidemiology
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / prevention & control
  • Carcinoma, Hepatocellular / virology
  • Health Services Accessibility*
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / epidemiology
  • Humans
  • Liver Cirrhosis / mortality
  • Liver Cirrhosis / prevention & control
  • Liver Cirrhosis / virology
  • Liver Neoplasms / mortality
  • Liver Neoplasms / prevention & control
  • Liver Neoplasms / virology

Substances

  • Antiviral Agents